Skip to main content
Neural Regeneration Research logoLink to Neural Regeneration Research
. 2019 Oct 18;15(4):653–662. doi: 10.4103/1673-5374.266911

Therapeutic importance of hydrogen sulfide in age-associated neurodegenerative diseases

Rubaiya Tabassum 1,2, Na Young Jeong 1,2,*, Junyang Jung 3,*
PMCID: PMC6975154  PMID: 31638087

Abstract

Hydrogen sulfide (H2S) is a gasotransmitter that acts as an antioxidant and exhibits a wide variety of cytoprotective and physiological functions in age-associated diseases. One of the major causes of age-related diseases is oxidative stress. In recent years, the importance of H2S has become clear, although its antioxidant function has not yet been fully explored. The enzymes cystathionine β-synthase, cystathionine γ-lya-se, and 3-mercaptopyruvate sulfurtransferase are involved in the enzymatic production of H2S. Previously, H2S was considered a neuromodulator, given its role in long-term hippocampal potentiation, but it is now also recognized as an antioxidant in age-related neurodegeneration. Due to aerobic metabolism, the central nervous system is vulnerable to oxidative stress in brain aging, resulting in age-associated degenerative diseases. H2S exerts its antioxidant effect by limiting free radical reactions through the activation of antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase, which protect against the effects of aging by regulating apoptosis-related genes, including p53, Bax, and Bcl-2. This review explores the implications and mechanisms of H2S as an antioxidant in age-associated neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and Down syndrome.

Keywords: 3-mercaptopyruvate sulfurtransferase, aging, antioxidant, cystathionine ß-synthase, cystathionine γ-lyase, glutathione, hydrogen sulfide, neurodegenerative disease, oxidative stress, reactive oxygen species

Introduction

Hydrogen sulfide (H2S) has organic outcomes in living organisms, especially with respect to cell signaling and post-transcriptional modifications. H2S is the third gasotransmitter identified in mammalian cells (Gemici et al., 2015). H2S has been recently shown to be produced by a number of tissues where it exerts biochemical and physiological effects (Rose et al., 2017). As an endogenous signaling molecule, H2S has significant effects on the nervous system. Substantial evidence also exists that H2S inhibits free radical reactions in aging and age-associated neurodegenerative diseases.

Cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate (3MST) are important for H2S production (Xie et al., 2016). The expression of H2S is catalyzed by these enzymes. Parkinson’s disease (PD) is expressed in the murine brain and kidney, CSE in the liver and peripheral tissue, and 3MST in the brain, liver, kidney, and aorta (Kabil and Banerjee, 2014). The proper contribution of 3MST compared with CBS and CSE in the production of endogenous H2S is currently under investigation (Singh and Banerjee, 2011). H2S also acts as a modulator in age-associated neurodegenerative diseases of the CNS, including Alzheimer’s disease (AD), PD, Huntington disease (HD), and Down’s syndrome (DS). The thiol containing the toxic molecule homocysteine enhances the vulnerability of neural cells through excitotoxicity and an elevated level of plasma homocysteine (Cai et al., 2016). H2S reduces the neurotoxicity of homocysteine by acting as a synaptic modulator (Seshadri et al., 2002). H2S exerts its antioxidant function through superoxide super oxide dismutase (SOD), glutathione peroxidase (Gpx), and catalase (CAT) which combat free radicals (Dorrell et al., 2009). As H2S is an antioxidant signaling molecule that interacts with other gasotransmitters, including nitric oxide (NO) and carbon monoxide, which increase or decrease the action of H2S. In this review, we describe the potential causes of oxidative stress and the antioxidant function of H2S in age-associated neurodegenerative diseases.

Database Search Strategy

We searched NCBI, Google scholar, and Medline for literatures regarding oxidative stress, H2S, aging, reactive oxygen species, antioxidant and therapeutic importance of H2S in neurodegenerative diseases published from inception to March 1, 2019 (Additional Table 1).

Additional Table 1.

Database search strategy

Serial No. Article title Eligibility criteria Key words Publicati on date Database Publishing language
1 Hydrogen sulfide: a therapeutic option in systemic sclerosis A review that describes hydrogen sulfide (H2S), therapeutic potential of H2S, H2S in animal studies Systemic sclerosis, therapeutic interventions, gasotransmitters December 19, 2018 NCBI English
2 Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway This review highlighted the role of H2S and KATP channel-dependent pathway Ca+ channel, KATP channel, cystathionine-γ-lyase (CSE) and cystathionine-β-synthetase July 18, 2007 NCBI English
3 Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells This article demonstrates the genetic construction of neurodegenerative diseases Alzheimer’s disease (AD), Huntington disease (HD), Parkinson’s disease, CAG repeats, pluripotent stem cells June 28, 2012 NCBI English
4 Evidence that hydrogen sulfide is a genotoxic agent An article that describes about genomic instability or the cumulative mutations H2S, DNA damage, NaHS, colorectal cancer January, 2006 NCBI English
5 Mitochondrial dysfunction in mouse trisomy 16 brain nephrology Studies that have started to identify oxidative stress, mitochondrial dysfunction, neurodegenerative disease, Parkinson’s disease Pyruvate dehydrogenase, Parkinson’s disease, Down syndrome January 10, 2008 Google Scholar English
6 The signals and pathways activating cellular senescence The purpose is to demonstrate signals and pathways activating senescence Oxidative stress, DNA damage, p53, telomeres May, 2005 Google Scholar English
7 Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson’s disease This review article summarizes the current body of evidence demonstrating the cytoprotective effects of H2S Hydrogen sulfide, oxidative stress, mitochondrial dysfunction, Parkinson’ disease (PD) November 8, 2018 NCBI English
8 Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides This article tells about advanced glycation and lipoxidation end products (AGEs/ALEs) implicated in the pathogenesis of the major microvascular complications of diabetes mellitus: nephropathy, neuropathy AS Angeli’s salt, cGMP, cyclic guanylate monophosphate, GSH; glutathione GSNO; glutathione S-nitrosothiol GSSG; oxidized glutathione, GSSH; glutathione persulfide, NOS; nitric oxide synthase, PLP; pyridoxal-5′-phosphate, SNP; sodium nitroprusside February, 2013 Google scholar English
9 Redox proteomics identification of oxidatively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorder In this review, it has been discussed oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer’s disease Cognitive impairment, AD, glutamate synthetase (GLUL) May, 2006 NCBI English
10 Amyloid β-peptide (1–42)-induced oxidative stress in Alzheimer’s disease: importance in disease pathogenesis and progression This article discusses amyloid β-peptide (1–42)-induced uxidative stress in Alzheimer’s disease Aβ, oxidative stress, AD, amyloid beta precursor, reactive oxygen species August 16, 2013 NCBI English
11 Cystathionine γ lyase–hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes This study unravels CSE–H2S-mediated PPARγ activation might be a new therapeutic target for diabetes associated with obesity Cystathionine γ lyase, hydrogen sulfide, phosphodiesterase, peroxisome, proliferator-activated receptor γ, sulfhydration, obesity May, 2016 Google scholar English
12 Induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases This article tells about induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases Pluripotent stem cell, drug target, drug screening August 23, 2015 NCBI English Pluripotent stem cell, drug target, drug screening
13 A new hope for a devastating disease: hydrogen sulfide in Parkinson’s disease Protective effects can be described to mediate antioxidation, anti-inflammation, prosurvival activity and development of H2S in the treatment of PD H2S, brain modulation, antioxidant effect, H2S donors May, 2018 NCBI English
14 Parkin absence accelerates microtubule aging in dopaminergic neurons This study investigates microtubules aging in dopaminergic neurons Microtubule tubulin post-translational modifications, Parkin Parkinson’s disease, aging, dopaminergic neurons January, 2018 NCBI English
15 Aggresome formation and neurodegenerative diseases: therapeutic implications This study indicates a aggresome formation and neurodegenerative diseases and therapeutic implications Parkin, neurodegenerative diseases, E-ubiquitin protein November 1, 2008 Google scholar English
16 Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies This article discusses overview of therapeutics that have been tested and some possible new therapeutics that can be tested in IPSC models of PD Oxidative stress, mitochondrial dysfunction, PD November 8, 2018 Google scholar English
17 The use of mouse models to understand and improve cognitive deficits in Down syndrome Discusses about the distribution of targets and in the pathways that are affected by these diverse drugs in the trisomic brain suggest new avenues for DS research and drug development Down syndrome, cognitive deficits 2011 Google scholar English
18 Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation This study investigated mutations shift native tetramers to monomers as a mechanism for disease initiation α-Syuclein, Parkinson’s disease, protein aggregation 2015 NCBI English
19 Therapeutic potentials of plant iridoids in Alzheimer’s and Parkinson’s diseases This study investigated therapeutic potentials of plant iridoids in Alzheimer’s and Parkinson’s diseases Glial cell, neuroinflammation, insulin, oxidative stress May 1, 2019 Google Scholar English
20 Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress Neuronal loss secondary to NV can be prevented by the use of simple antioxidant dietary measures or cell-based delivery of neurotrophic factors, even when the underlying vascular phenotype is not altered Oxidative stress, neurovasculorization, antioxidant February 2, 2019 NCBI English
21 Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species This research discusses glutathione metabolism in brain Glutathione, Gpx, hydrogen peroxide, (H2O2) December 25, 2001 NCBI English
22 Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway This study suggested endogenous H2S inhibited ox-LDL-induced macrophage inflammation by suppressing NF-κB p65 phosphorylation, nuclear translocation, DNA binding activity, and recruitment to the MCP-1 promoter H2S,NF-κB pathway, macrophages, phosphorylation February 18, 2018 NCBI English
23 Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington’s disease This article highlight advances cystag in Huntington’s disease (HD) CAG repeats, oxidative stress, HD October 28, 2005 NCBI English
24 Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract Cystathionine β synthase, cyclic guanylyl cyclase, carbon monoxide, cystathionine ɤ lyase, H2S Oxidative stress, antioxidant, neuropsychiatric disorder August, 2014 Google Scholar English
25 Redox modulations, antioxidants, and neuropsychiatric disorders This study introduuce the complex topics of redox modulations and their role in the development of select neuropsychiatric disorders Oxidative stress, antioxidant, neuropsychiatric disorder June 14, 2015 NCBI English
26 Hydrogen sulfide as a gasotransmitter This review discusses physiologic gasotransmitter of comparable importance to NO and carbon monoxide Nitric oxide synthase, NO, CO March 3, 2010 Google Scholar English
27 Hydrogen sulfide as an allosteric modulator of ATP- sensitive potassium channels in colonic inflammation The authors provides sulfhydration of SUR2B induces allosteric modulation of KATP currents in colonic inflammation Potassium channel, H2S, sulfhydration January, 2103 Google Scholar English
28 Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in alzheimer’s disease and parkinson’s disease Identify putative neuroprotective strategies that would be beneficial in both the clinical conditions Proteinopathy, amyloid beta, oxidative stress, α-synuclein, mitochondrial dysfunction March, 2017 Google Scholar English
29 H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential This article describes H2S-releasing drugs: Anti-inflammatory, cytoprotective and chemopreventative potential Gastrointestinal, cytoprotection, inflammation, hydrogen sulfide, drug development April 30, 2015 NCBI English
30 Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models The authors demonstrate H2S as a neuroprotectant to treat and prevent neurotoxin-induced neurodegeneration via multiple mechanisms including anti-oxidative stress, anti-inflammation and metabolic inhibition and therefore has potential therapeutic value for treatment of PD CBS, PD, CSE, H2S, neurodegenerative disease March 16, 2010 Google scholar English
31 Bioassay-comparison of the antioxidant efficacy of hydrogen sulfide and superoxide dismutase in isolated arteries and veins This study addressed that H2S is a less effective vascular antioxidant than SOD. We propose that the previously described beneficial effects of H2S are unlikely to be related to its direct effect on superoxide Hydrogen sulfide, super oxide dismutase (SOD) December 12, 2013 NCBI English
32 Hydrogen sulfide and cell signaling: team player or referee? Current state of play of effects of hydrogen sulfide in plants Glutathione, Hydrogen peroxide, Hydrogen sulfide, Nitric oxide, Signal transduction, Thiol modifications Of hydrogen 2014 NCBI English
33 SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model Explain about the gain-of-function seen with certain SOD1 mutations associated with ALS and defines new therapeutic targets ALS, SOD1, GTPase activity, oxidation January 24, 2008 Google Scholar English
34 Emerging biological importance of central nervous system lanthionines The potential significance of lanthionines in paracrine signaling is discussed with reference to opportunities for utilizing bioavailable pro-drug derivatives of these compounds as novel pharmacophores Lancl2, pro-drug derivatives, cysteine, CNS August 13, 2020 Google Scholar English
35 Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun Telomeres are important targets for stress in vitro and in vivo and this has important consequences for the ageing process DNA damage, aging, oxidative stress, cellular scenoscence February 28, 2012 Google Scholar English
36 Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol This article provides an overview of age-related changes in the defense systems, enzymatic and non-enzymatic, which normally counter generation of altered proteins are also discussed Oxidation, ROS, Glycation Aldehydes AGEs, Deamidation Cross-linking Proteolysis, Aggregation, Proteasomes, Lysosomes, Mitochondria May, 2006 Google Scholar English
37 levation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function Elevation of basal [Ca 2+]i could thus prove a central element in the regulation of executive functions in activated microglia Calcium channel, nitric oxide, calcium signaling, CNS June 1, 2003 NCBI English
38 Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models The role of H2S and its therapeutic potentials Hydrogen sulfide, 6-OHDA, Rotenone, MPTP, Parkinson’s disease 2014 NCBI English
39 Hydrogen sulfide upregulates glutamate–cysteine ligase catalytic subunit, glutamate– cysteine ligase modifier subunit, and glutathione and inhibits interleukin-1β secretion in monocytes exposed to high glucose levels Beneficial effects of H2S-rich compounds in mitigating the pathogenesis of metabolic syndrome and atherosclerosis Glutathione, glutamate, GCLC,GCLM 22 May, 2014 NCBI English
40 Hydrogen sulfide-mechanisms of toxicity and development of an antidote This study suggests sulfide produces a high degree of oxidative stress in cells and tissues, and that cobinamide has promise as a first specific treatment for sulfide poisoning H2S, cytochrome c oxidase 2016 NCBI English
41 Enzymology of H2S biogenesis, decay and signaling This review focuses on the enzymology of H2S homeostasis and discuss H2S-based signaling via persulfidation and thionitrous acid H2S biogenesis, CBS, S-adenylyl cyclase January 28, 2014 NCBI English
42 H2S and its role in redox signaling The chemical properties of H2S and its varied physiological effects are discussed Redox, Thiol, Hydrogen sulfide 2016 NCBI English
43 Sulfur as a signaling nutrient through hydrogen sulfide This review provides an overview of sulfur metabolism hydrogen sulfide, signaling, sufur metabolism, nutrition, su lfide oxidation July, 2014 NCBI English
44 Mental retardation in Down syndrome: a hydrogen sulfide hpothesis The Cl−-dependent transport site to which glutamate and quisqualate (but not kainate or NMDA) bind has a higher affinity for cystine than for glutamate Cytotoxicity, NMDA, glutamate NCBI English
45 Hydrogen sulfide and polysulfides as biological mediators Mitochondrial ROS generation may be important for regulation of mitochondrial uncoupling protein (UCP) activity and thus disruption of cellular energy metabolism, the NADPH oxidase associated ROS may alter parameters of signal transduction, insulin secretion, insulin action and cell proliferation or cell death Oxidative stress, redox signaling, neurodegenerative disease, DNA oxidation, protein oxidation, ROS, type 2 diabetes August 15, 2007 NCBI English
46 Hydrogen sulfide and polysulfides as signaling molecules Normalizing levels of mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation and NFkappaB activation. NFκB, hyperglycemia, oxidative stress, TCA April 13, 2000 NCBI English
47 Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria Diabetes, synapse dysfunction is, at least in part, caused by a failure of BDNF synthesis in the brain. Brain-derived neurotrophic factor Diabetes Learning memory Y-maze task Rats October, 2002 NCBI English
48 Hydrogen sulfide protects neurons from oxidative stress This review highlights the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications T2DM, oxidative stress, AGEs March 16, 2015 NCBI English
49 Hydrogen sulfide chemical biology: pathophysiological roles and detection This review examines different strategies for managing diabetic neuropathy which rely on exogenous antioxidants DN, oxidative stress, antioxidant, hyperglycemia 2015 NCBI English
50 Modeling neuropsychiatric and neurodegenerative diseases with induced pluripotent stem cells The purpose of this study is to perform an updated meta-analysis to investigate the up-to-date pooling evidence based on published population-based cohort studies and assess the association between DM and the risk of PD. Diabetes mellitus, PD May 1, 2016 NCBI English
51 Modeling Parkinson’s disease using patient-specific induced pluripotent stem cells Novel pharmacological strategies aimed at removing peroxynitrite might represent powerful therapeutic tools in the future. Evidence supporting these novel roles of NO and peroxynitrite is presented in detail in this review Nitric oxide, oxidation, DNA oxidation Jan, 2007 NCBI English
52 Hydrogen sulfide and cell signaling This article indicated that PD might exert protective effects against OSI through various interactions with PKC pathway Glutathione, PD, PKCs, oxidative stress 2016 NCBI English
53 Hydrogen sulfide attenuates chronic restrain stress- induced cognitive impairment by upreglulation of Sirt1 in hippocampus H2S targets mitochondria at low micromolar concentrations via reversible inhibition of cytochrome c oxidase CBS, CSE, 3MST, ATP, hydrogen sulfide 2008 NCBI English
54 The hallmarks of aging The regulation of expression of protooncogenes and apoptosis (programmed cell death), the development of diseases such as cancer and human immune deficiency may be affected by depleting or elevating cellular GSH level NAC, GSH, oxidative stress, antioxidant September 29, 2008 NCBI English
55 The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels Free radical scavengers, or over expression of antioxidant enzymes in islets or transgenic mice can protect β cells from oxidative stres Insulin, oxidative stress, apoptosis, beta cell death October, 2010 NCBI English
56 Slow regulated release of H2S inhibits oxidative stress induced cell death by influencing certain key signaling molecules This review focuses on the relationship between oxidative stress and neuroinflammation in the development and progression of diabetic neuropathy NF-κB, Oxidative stress, inflammation February 27, 2014 NCBI English
57 Biosynthesis and functions of glutathione, an essential biofactor This review addresses recent findings on such lipohormetic mechanisms that are associated with lipid peroxidation in pancreatic beta cells. This articl Beta cells, oxidative stress, lipid peroxidattion, type 2 diabetes 2017 NCBI English
58 Hydrogen sulfide is produced by cystathionine γ-lyase at the steady-state low This tells about the history of diabetes or the use of antidiabetes drugs was associated with Parkinson’s disease a history of diabetes or the use of antidiabetes drugs was associated with Parkinson’s disease May, 2011 Google Scholar English
intracellular Ca2+ concentrations
59 Mitochondrial role in cell aging the mechanism of glutamate-induced oxidative damage, neuroinflammation, and neuroprotection by polyphenolic anthocyanins in PND7 Oxidative stress, neuroinflammation, neuroprotection June 6, 2016 Google Scholar English
60 Cytokine-induced GAPDH sulfhydration affects PSD95 degradation and memory H2S-induced modification of GAPDH appears to be an essential posttranslational modification of GAPDH that is required for IL-1β-induced synapse loss in brain H2S, CBS, GAPDH December 18, 2014 NCBI English
61 In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage This article present a new perspective on H2S production and storage in the brain 3-MST,CAT, hydrogen sulfide April 2, 2002 NCBI English
62 Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer’s disease This paper discuss about combined therapy involving antioxidants and check points for synaptic plasticity during early stages of the disease could become a viable therapeutic option for AD treatment Cognitive decline, AD, oxidative stress, antioxidant July 10, 2013 NCBI English
63 Exercise improves efficacy of levodopa in patients with Parkinson’s disease The objective of this article is to investigate the impact of exercise on absorption and efficacy of levodopa (LD) in patients with PD Levodopa, PD, absorption February 15, 2007 NCBI English
64 Cellular senescence: from physiology to pathology This article demonstrated about cellular senescence promotes tissue remodeling through three sequential processes: a stable proliferative arrest; a secretory phenotype (SASP) that recruits immune cells and modifies the extracellular matrix; and the mobilization of nearby progenitors that repopulate the tissue. We refer to this sequence of events as the senescence– clearance–regeneration model Cellular senescence, embryonic development, type 2 diabetes June 23, 2014 NCBI English
65 Antioxidant gene therapy against neuronal cell death This study investigated oxidative stress in neuronal cell death associated with neurodegenerative disorders AD, Aβ, BDNF, SOD February 17, 2011 NCBI English
66 Involvement of oxidative stress in Alzheimer disease This study describes oxidatively modified macromolecules are present in biologic fluids from the patients with AD as well as cellular and animal AD models Apoptosis, AD, NFTs, oxidative stress July, 2006 NCBI English
67 Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome This article leads to the expectation that oxidative damage should positively correlate with Aβ deposition Alzheimer disease, Amyloid-β, Down syndrome, 8-hydroxyguanosine, Nitri c oxide, nitrotyrosine, Oxi dative damage November 1, 2000 NCBI English
68 Generation and characterization of human induced pluripotent stem cells This research describes about detection of pluripotent cell markers, embryoid body differentiation, and teratoma differentiation are used to determine pluripotency in vitro and in vivo, respectively iPSC cells, in vivo differentiation, in vitro differentiation June 1, 2009 NCBI English
69 Small molecules as therapeutic drugs for Alzheimer’s disease In this article mitochondrial dysfunction has been implicated in aging and age-related neurodegenerative diseases are discussed AD, mitochondria-targeted molecules, oxidative stress, PD, mitochondrial dynamics, aging April, 2019 NCBI English
70 Hydrogen sulfide as an oxygen sensor pathway in rats This article describes pathophysiological responses and possible therapeutic uses This article describes H2S interaction with gasotransmitters November 30, 2013 NCBI English
71 Mitochondrial dysfunction in Alzheimer’s disease and the rationale for bioenergetics based therapies This article suggested an involvement of the peripheral IGF-I trophic system in ALS ALS, IGF-I trophic system in ALS NCBI English
72 H2S: a novel gasotransmitter that signals by sulfhydration Investigations have indicated that diabetes-induced changes of brain properties might, in fact, share many properties with brain ageing Diabetes mellitus, Synaptic plasticity Long-term potentiation, Glutamate receptor 2004 NCBI English
73 Apoptosis inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins Deletion of endogenous tdp-1 rescues mutant TDP-43 and FUS proteotoxicity in C. elegance. These results suggest that chronic induction of wild- type TDP-1/TDP-43 by cellular stress may propagate neurodegeneration and decrease lifespan ALS, TDP-43, oxidative stress, aging July 5, 2012 NCBI English
74 Oxidative stress and down syndrome: A route toward Alzheimer-like dementia The chronic inflammatory response and oxidative stress associated with T2DM, amyloid-β (Aβ) protein accumulation, and mitochondrial dysfunction link T2DM and AD SOD1, ALS, antioxidant 2015 Google Scholar English
75 The role of hydrogen sulfide in aging and age-related pathologies mutant SOD1-induced destructive events favors recruitment of astrocytes to non-cell autonomous injury in ALS ROS, Oxidative stress, hydrogen sulfide donor, NOS January, 2108 NCBI English
76 Homocysteine metabolism in children with Down syndrome: in vitro modulation Oxidative stress and oxidative damage are a result of concurrent accumulation of mtDNA mutations and defective antioxidant enzymes in human aging. ROS, Oxidative stress, hydrogen sulfide donor 2002 NCBI English
77 Carbamoylation abrogates the antioxidant potential of hydrogen sulfide These findings can significantly advance therapeutic approaches to the neurodegenerative diseases which are associated with oxidative stress, such as Parkinson’s disease Hydrogen sulfide donor, PD, NaHS, PC12 cells August 12, 2009 NCBI English
78 Hydrogen Sulfide in Biochemistry and Medicine This article discusses the current status of T1D susceptibility loci and candidate genes with focus on pancreatic islet cell inflammation and β-cell apoptosis Beta cells, oxidative stress, lipid peroxidation, type 2 diabetes February 16, 2017 NCBI English
79 Brain phenotype of transgenic mice overexpressing cystathionine β-synthase A key enzyme of sulfur-containing amino acid (SAA) metabolism, a pathway important for several brain physiological processes Hsa21, DS, H2S January 12, 2012 NCBI English
80 Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease This review discusses evidence for the neuropathological role for α-synuclein in the dysfunction of dopamine neurons in PD Α-synuclein, PD, post-transcriptional modification, H2S, sulfhydration January, 2018 NCBI English
81 Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21 Deleterious role of oxidatively modified molecules in early cell senescence of T21F, thereby linking replicative and stress-induced senescence in cultured cells to premature aging in DS SOD1, SOD2, trismy21, mRNA February 19, 2015 NCBI English
82 H2S biosynthesis and catabolism: new insights from molecular studies Conventional use of pharmacological and molecular approaches has spawned a rapidly growing research field that has identified H2S as playing a functional role in cell- signaling and post-translational modifications H2S, biosynthesis, catabolism, molecular models November 14, 2016 NCBI English
83 Human-induced pluripotent stem cells: potential for neurodegenerative diseases In this review, it has been discuss induced pluripotent stem cells (iPSCs). The ability to generate pluripotent stem cells from adult fully differentiated cells such as skin fibroblasts was a major advance in medicine in recent years iPSC, aging, PD, RNA metabolism May 13, 2014 NCBI English
84 Direct measurement of catalase activity in living cells and tissue biopsies High-sensitive measurement system for measuring diffusion-limited enzyme-substrate kinetics in real time. Using catalase (enzyme) and hydrogen peroxide (substrate) as the example pair, we demonstrate that this system is capable of direct measurement of catalase activity in vitro and the measured kinetics follows the classical Michaelis- Menten reaction kinetics Catabolism, H2S, hydrogen peroxide January 29, 2016 NCBI English
85 Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down’s syndrome An increased basal generation of superoxide in Ts16 neurons, probably caused by a deficient complex I of mitochondrial electron transport chain, which leads to an impaired mitochondrial energy metabolism and finally neuronal cell death Trisomy 16, Down’s syndrome, Alzheimer’s disease, Reactive oxygen species, Superoxide anion NAD(P)H, autofluorescence, Hippocampal culture, Free radicals January 15, 2000 NCBI English
86 Special delivery from mitochondria to peroxisomes Mitochondrial trafficking might play drawing upon knowledge of similar transactions between other organelles Peroxisome, mitochondrial membrane, SOD1, SOD2 June, 2008 NCBI English
87 Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions TNF-α stimulates the transcription of CSE and the generated H2S sulfhydrates cysteine-38 of p65, enhancing its binding to the coactivator RPS3, thereby augmenting binding to the promoters of several antiapoptotic genes NF-κB, TNF-α-induced cell death, H2S January 13, 2012 Google Scholar English
88 Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease Plasma total homocysteine in relation to newly diagnosed dementia and Alzheimer’s disease in the elderly, population-based cohort of Framingham Study participants Homocysteine, H2S, AD, cohort study, cognitive impairment February 14, 2002 Google Scholar English
89 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain H2S is produced by 3MST from cysteine and a-KG through metabolism by CAT, and that the produced H2S may immediately be stored as bound sulfane sulfur in the brain. These observations provide a new insight into the production and storage of H2S in the brain H2S, 3-mercaptopyruvate, 3-MST, CBS, CSE, CAT February 24, 2009 Google Scholar English
90 PLP-dependent H2S biogenesis This review focuses on the kinetics, structures and regulation of PLP-dependent enzymes involved in the evolution of H2S in mammals PLP, H2S, Cystathionine β-synthase, Cystathionine γ-lyase, Cysteine aminotransferase November, 2011 Google Scholar English
91 Hydrogen sulfide: a novel signaling molecule in the central nervous system. The role of H2S as an important mediator in a myriad of neural functions inclusive of neuroprotection is also discussed throughout the review H2S, Signal transduction, Nervous system January, 2010 Google Scholar English
92 Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease This findings provide a fundamental and general mechanism for oxygen-sensitive regulation of mitochondrial functions by linking oxygenation level to the accumulation/degradation of mitochondrial heme proteins H2S, Ca2+ channel mediated cytochrome C release June 21, 2013 Google Scholar English
93 Molecular mechanisms of hydrogen sulfide toxicity H2S can reduce intracellular bound ferric iron to form unbound ferrous iron, which activates iron. Additionally, H2S can increase the hepatocyte formation of reactive oxygen species (ROS) H2S, EDTA, NaHS, GSH, cytotoxicity, autoxidation October 9, 2008 Google Scholar English
94 H2S Protects Against Methionine–Induced Oxidative Stress in Brain Endothelial Cells The role of H2S in the regulation of oxidative stress in endothelial cells is still unclear. In addition, H2S acts as an endogenous scavenger for reactive oxygen species and reactive nitrogen species (RNS) N-acetyl-cysteine, CAT, H2S, GSH, thioredoxin, hyperhomocysteinemi a, oxidative stress Google Scholar English
95 The free radical theory of aging revisited: the cell signaling disruption theory of aging. antioxid redox signal Over-expressing Arf and p53 led to a significant increase in longevity in animals, which was independent of tumor protection conferred by p53 Aging, MnSOD, ZnSOD, glutathione peroxidase (Gpx) August 16, 2013 Google Scholar English
96 Therapeutic benefits of H2S in Alzheimer’s disease Physiological and pathological functions of H2S in the CNS AD, H2S, Antioxidation, Anti-apoptosis, Anti-inflammation, β-amyloid October, 2014 Google Scholar English
97 Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes This study investigates electrophysiological responses of human pluripotent stem cells (hPSCs) derived cardiomyocytes towards H2S hiPSCs, H2S, hESCs, action potential, electrophysiology November 30, 2012 Google Scholar English
98 An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system This review discusses the current understanding of individual and interactive regulatory functions of H2S and NO in biosynthesis, angiogenesis, vascular one, cardioprotection, and posttranslational modification, indicating the importance of their cross-talk in the cardiovascular system H2S, NO, posttranscriptional modifications, angiogenesis September 9, 2018 Google Scholar English
99 Hydrogen Sulfide and Cellular Redox Homeostasis The antioxidant effect of H2S has been most extensively investigated and was thought as the major mechanism underlying the effects of H2S H2S, mechanism, oxidative stress, reactive oxygen species, xanthine oxide December 1, 2015 Google Scholar English
100 Structural insights into pathogenic mutations in heme-dependent cystathionine-β-synthase Cystathionine β-synthase represent the single most common cause of severe hereditary hyperhomocysteinemia CBS, Homocysteine, Hemeprotein, Mutations December, 2006 Google Scholar English
101 In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets Mutant htt-directed repression mechanism involving multiple specific components of the basal transcription apparatus Htt, polyglutamine, CREB binding protein December 29, 2005 Google Scholar English
102 Hydrogen sulfide therapy in brain diseases: from bench to bedside H2S produced in mitochondria, the major organelle that releases reactive oxygen species (ROS) causing toxic effects and ultimately leading to cell death, also may directly suppress oxidative stress through scavenging ROS Mitochondrial oxidation, H2S, ROS, and neuronal function NCBI English
103 S sulfhydration of MEK1 leads to PARP-1 activation and DNA damage repair In the presence of H2S, activated PARP-1 recruits XRCC1 and DNA ligase III to DNA breaks to mediate DNA damage repair, and cells are protected from senescence H2S, CSE, DNA damage, poly-ADP ribose 2014 NCBI English
104 Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats A gaseous transmitter fulfilling a physiological role in regulating cardiovascular function. The mechanisms underlying the vascular relaxant effect of H2S are incompletely understood, although opening of ATP-sensitive K+ (KATP) channels in vascular smooth muscle cells may play an important role Potassium channel, H2S, NaHS, CSE January 1, 2007 NCBI English

Oxidative Stress and Aging

Aging is the common result of oxidative stress. Reactive oxygen species (ROS) accumulation by mitochondria is mostly found in aged tissue (Viña et al., 2013). High levels of 8-Oxo-2′-deoxyguanosine, which result in oxidative harm, are commonly found in mtDNA (Hipkiss, 2006). According to the free radical theory of aging, discovered by Harman in 1954, aggregation of protein, lipid, and DNA molecules in mitochondria are responsible for cellular senescence (Miquel et al., 1980). Protein oxidation due to excessive oxidative stress is triggered by several signaling pathways, including transforming growth factor-β signaling, the DNA damage response, and mitogen activated protein kinase 2K3 (MAPK2K3) signaling, which is responsible for increased regulation of the cell cycle inhibitor, p53 (Muñoz-Espín and Serrano, 2014).

On the other hand, ongoing research has demonstrated that thiol and thiol-related enzymes, including Gpx, are linked with the progression of aging (Muñoz-Espín and Serrano, 2014). Gpx deficiency leads to increased levels of oxidative stress. Although the balance of ROS plays a vital role in enhancing or suppressing cellular fates such as proliferation and differentiation, the increased level of oxidative stress is considered a major mediator of aging (Ben-Porath and Weinberg, 2005). Moreover, protein aggregation has also been linked with aging. In particular, the aggregated protein, lipofuscin, is a hallmark of aging. Transitional metals bind lipofuscin to produce more ROS through the Fenton reaction (Ben-Porath and Weinberg, 2005). Under pathophysiological conditions, the aggregation of oxidized protein is irreversible. Proteins may appear as inclusion bodies, lysosomes, aggresomes, or plaques, and may affect normal cellular metabolism (Chin et al., 2008).

Taken together, these data suggest that oxidative stress is the root cause of aging that increases with age-related diseases. The contribution of ROS in protein oxidation is still unclear and will require further investigation.

Oxidative Stress and Mitochondrial Dysfunction in Neurodegeneration

Neurodegeneration is very common in elderly people. Oxidative stress is one of the major causes of these neurodegenerative diseases in aging (Ganguly et al., 2017). The molecular link between oxidative stress and neurodegeneration can vary disease to disease like Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington disease (HD), and Down’s syndrome (DS). For example, ROS-rseponsive transcription factors can alter the expression of genes encoding such toxic proteins or the enzymes involved in the synthesis, processing, and degradation of such proteins which causes mitochondrial dysfunctions (Ganguly et al., 2017). In some conditions, the mutant gene produces an abnormal product that is not readily cleared by the protein degradation machinery, leading to its accumulation, and a similar thing can happen if the protein is posttranscriptionally modified because of redox status and the activity of kinases (Ciechanover and Kwon, 2015). In AD pathology, oxidative damage results in deposition of Aβ protein which triggers the neurodegeneration process (Dinda et al., 2019). In addition to this, oxidative damage causes decreased synthesis of adenosine tri phosphate (ATP), leading to mitochondrial membrane depolarization. In particular, extensive studies have been conducted using transgenic AD models, postmortem AD brain, cultured cells and isolated mitochondria through multiple mechanisms (Onyango et al., 2016). In transgenic AD mice and postmortem AD brain, progressive deposition of Aβ occurs in brain mitochondria (Onyango et al., 2016). Moreover, human induced pluripotent stem cell (hiPSC) models of AD have been generated from patients with amyloid precursor proteins (APP) mutations, including an E693 deletion which showed oxidative stress (Ross and Akimov, 2014). Oxidative stress is also responsible for accumulation of phosphorylated tau proteins within the neurons which might result in translation of a specific mRNA (Oliver and Reddy, 2019). In AD, increased phosphorylation of tau protein is the result of increased activities of glycogen synthase kinase 3 beta (GSK3β) and cluster of differentiation (CDK5) (Mondragón-Rodríguez et al., 2013). Moreover, significant accumulation of transitional metals such as Fe, Cu, and Zn causes impaired antioxidant defense (Butterfield et al., 2013).

Oxidative stresses also have their detrimental effects on PD and HD. The most common mitochondrial proteins PINK1 and PARK2 show dysfunctional properties (Rocha et al., 2018). PINK1 is normally on the inner mitochondrial membrane, but it migrates to the outer membrane to phosphorylate proteins due to oxidative stress when there is a reduction in mitochondrial membrane (Bose and Beal, 2019). Parkin protein is involved in mitochondrial homeostasis and the loss of parkin protein causes the loss of quality control of mitochondria and degeneration of dopaminergic neurons in mid brain (Cartelli et al., 2018). Neurons derived from a hiPSC of patients who harbor the α-synuclein mutation show increased sensitivity to environmental toxins such as rotenone, paraquat which leads to the inhibition of the myocyte enhancer factor 2C-peroxisome proliferator activated receptor-γ coactivator-α (MEF2C-PGC1α), which in turn contributes to mitochondrial dysfunctions (Bose and Beal, 2019). HD is the autosomal-dominant neurodegenerative disorder that is caused by abnormal expansion of polyglutamine (CAG) repeats in the huntingtin (HTT) (An et al., 2012). HD is considered as an ideal disorder model for exploring the effectiveness of iPSCs, because it is induced by a single gene, and there is a strong correlation between the length of the CAG repeat expansion and the onset of age disease (Cao et al., 2015). Cao et al. (2015) reported on the successful correction of the CAG repeat-expanded HTT allele in HD patient iPSCs. When evaluated with a series of experiments, HD consortium revealed that cells carrying the longer repeats were more vulnerable to cellular stresses and brain-derived neurotrophic factor deprivation, demonstrating the correlation of CAG repeat lengths with disease onset.

DS represents one of the best documented cases of a human disorder related to the redox imbalance that has been attributed by Cu, Zn-SOD1 and encoded by trisomic chromosome 21 (Rodríguez-Sureda et al., 2015). As an essential link to oxidative stress, mitochondrial dysfunctions are observed whenever redox imbalances occur. Bambrick and Fiskum (2008) reported a defective repair of oxidative damage to mitochondrial DNA (mtDNA) in fibroblasts from DS patients, while Schuchmann and Heinemann found mitochondria-associated anomalies in neurons from Ts16 mice. Superoxide formation was significantly increased in Ts16 neurons compared with control neurons (Schuchmann and Heinemann, 2000). A selective decrease in respiration was detected with the Complex I substrates malate and glutamate but not with the Complex II substrate succinate in isolated cortex mitochondria from Ts16 mice (Bambrick and Fiskum, 2008). Under oxidative stress condition, some markers like AGEs, dityrosine, and H2S are found at increased levels in DS patients which are responsible for aging and neurodegeneration (Perluigi and Butterfield, 2012).

In a nutshell, oxidative stress has a progressive role in age-associated neurodegenerative diseases. H2S might act as a therapeutic target for these neurodegenerative diseases from different perspectives.

Role of H2S in the Regulation of Aging

H2S plays various physiological roles in the human body by preventing oxidative damage or deterioration. Most age-associated diseases are a result of oxidative stress, whereas antioxidants increase longevity. Oxidative stress derivatives appear as ROS and RNS, such as super oxide (O2•–), hydrogen peroxide (H2O2), and NO (Zhu et al., 2007; Tyagi et al., 2009). H2S has been shown to exhibit protective effects on mouse endothelial cells (bEnd3) against methionine-induced oxidative stress. According to the free radical theory, SOD converts O2•– to H2O2, which is then converted into H2O and O2 by CAT (Kimura et al., 2010). In the presence of reduced GSH, low concentration of H2S broadly inhibits cellular damage by the reactive nitrogen species (RNS) derivative ONOO (Viña et al., 2013). H2S also inhibits toxicity in human neuroblastoma SH-SY5Y cells through inhibition of ONOO (Viña et al., 2013).

The interrelationship between H2S and aging is based on several factors, including genomic instability (Attene-Ramos et al., 2006). Genomic integrity and stability is affected by exogenous and endogenous treats where most damage occurs in the nuclear genome (López-Otín et al., 2013). Nuclear DNA damage are one of the causes of neurodegeneration, whereas H2S attenuates DNA damage (López-Otín et al., 2013). In contrast to the nuclear genome, protection of mitochondrial DNA is not efficient and is heavily dependent on the machinery of nuclear DNA repair (Perridon et al., 2016). Mitochondrial DNA is more vulnerable to mutations due to the oxidative stress and the lack of protective histones on mitochondrial DNA (Perridon et al., 2016). Therefore, aging-associated mutations and deletions in the mitochondrial genome may also contribute to the aging process (Perridon et al., 2016). For instance, DNA is damaged by the treatment of fibroblasts with the H2S donor, NaHS, resulting in apoptotic cell death in a Bax and cytochrome C-dependent manner (Kimura et al., 2010). Telomerase, a specialized DNA polymerase, is required to elongate telomers as the replicative DNA polymerase lacks his capacity (Hewitt et al., 2012). Dysfunctional telomeres are highly efficient in inducing apoptosis during aging (Hewitt et al., 2012). In addition to this, epigenetic alterations such as posttranslation of histones, alterations in DNA methylation pattern and chromatin remodeling, can regulate the accessibility of DNA and underlie the differential gene transcription observed between cell types during aging (López-Otín et al., 2013). S-sulfhydration, as well as extracellular regulated kinase (ERK1/2), prevents DNA damage. H2S can activate poly ADP-ribose polymerase (PARP-1) and inhibit DNA damage in endothelial cells. PARP activation is mediated by the MEK/ERK pathway (Hancock and Whiteman, 2014). S-sulfhydrated MEK1 at cys341 induces ERK1/2 phosphorylation in the nucleus, which activates PARP-1 (Hancock and Whiteman, 2014). On the other hand, mutation of cys341 prevents the activation of PARP-1 (Zhao et al., 2014).

Experimental studies have reported that H2S provides protection when chronic restraint stress-exposed rats are treated with NaHS. In particular, H2S increased SOD activity and the level of GSH at an NaHS concentration of 30 or 100 μmol/kg, indicating the role of H2S in oxidative stress (Li et al., 2017). Kimura (2014) also reported that the concentration of intracellular cysteine in the presence of H2S exhibits an anti-aging function by inhibiting SIRT1, whereas SIRT1 has been identified in yeast as an NAD+-dependent histone deacetylase, which increases DNA stability. SIRT1 deficiency has been shown to hamper cognitive abilities and the antiaging role of SIRT1 is associated with the drug resveratrol (Figure 1B; Li et al., 2017).

Figure 1.

Figure 1

Biosynthesis of H2S from enzymatic source and anti-aging function of H2S.

(A) The synthetic procedure of H2S. (B) Anti-aging effect of H2S. This diagrammatic illustration reveals H2S formation in mitochondria. Most prominently, three enzymes, cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3MST) are the main precursors for H2S formation, where cytosol contains CBS and CSE and mitochondria contains 3MST. The origins of cytosolic H2S formation are homocysteine, cysteine, and L-cysteine which are derived from proteins and cysteine. In mitochondria, H2S is produced from 3 mercaptopyruvate (3-MP) and L-cysteine. H2S exerts metabolic function through upregulation of silent information regulator 1 (SIRT1) and inhibiting free radical-induced oxidative stress. H2S also inhibits cell aging through mediating super oxide dismutase/glutathione (SOD/GSH). Resveratrol, an anti-aging drug, initiates age-associated metabolic phenotypes by the inhibition of cyclic adenosine monophosphate (cAMP) phosphodiesterase (PDE). H2S enhances SIRT1 and inhibits PDE activity to provide anti-aging function. CAT: Cysteine acetyl transferase; DAO: diamine oxidase; H2S: hydrogen sulfide; RNS: reactive nitrogen species; ROS: reactive oxygen species.

Enzymatic Contribution to the Biosynthesis of H2S

The biosynthesis of H2S is mediated by three enzymes: CSE, CBS, and 3MST. Cystathionine is the metabolite formed by CBS via the condensation of homocysteine (Kimura, 2015), while CSE converts L-cysteine and α-ketoglutarate (α-KG). H2S is produced by the generation of pyruvate, ammonia, and L-cysteine. 3MST generates H2S through the formation of pyruvate from 3-mercaptopyruvate (3MP), which undergoes cysteine and α-KG metabolism associated with cysteine amino transferase (Figure 1A).

Contribution of CBS

CBS has traditionally been introduced as the initial enzyme in the transsulfuration pathway (Régnier et al., 2012). As the physiological function of CBS is to eliminate homocysteine, CBS deficiency results in homocystinuria, which is characteristic of many metabolic diseases (Yamanishi et al., 2006). The catalytic function of CBS is mediated by 63-kDa subunits, which bind to the co-factor, heme, and pyridoxal 5′ phosphate (PLP). CBS individually binds to two substrates (homocysteine and serine) whose activity is mediated by S-adenosyl-L-methionine (SAM) (Mikami et al., 2013). Moreover, CBS can produce H2S by three distinct pathways: (1) Converting cysteine and H2O to form serine and H2S; (2) condensation of cysteine and homocysteine to generate cystathionine and H2S; and (3) condensation of two cysteine molecules to form lanthionine and H2S (Singh and Banerjee, 2011). Under physiological conditions, CBS is cytosolic and H2S acts as a neurotransmitter under high expression of CBS (Kabil et al., 2014b). CBS has also been shown to translocate to the nucleus and mitochondria (Teng et al., 2013).

Contribution of CSE

CSE mediates H2S synthesis in smooth muscle cells through a PLP-dependent α, β-elimination reaction combined with cysteine. A high level of potentiation is observed during H2S synthesis by CSE, particularly in the presence of PLP, while suppression is observed at 300 nM Ca2+. This indicates that when H2S is generated by CSE in cells, the Ca2+ concentration is increased (Mikami et al., 2013). The binding site of CSE indicates the expression of CSE and explains the antiapoptotic function of H2S (Sen et al., 2012) produced by CSE, which makes an addition to the cysteine residues of nuclear factor kappa-B (NF-κB), activating antiapoptotic genes (Sen et al., 2012). Moreover, in western blot analysis, CSE has been detected as an H2S generator in the brain. Additionally, in a mouse model of HD, the level of CSE expression is low.

Contribution of 3MST and CAT

3MST and CAT also take part in H2S synthesis in brain tissue (Gadalla and Snyder, 2010), which is recognized as the third source of H2S production. 3MST also acts as alternative source to CBS for the synthesis of H2S (Shibuya et al., 2009). 3MP is a substrate of 3MST and is produced through cysteine metabolism and α-KG by CAT. 3MST and CAT localize to the mitochondria and synaptosomes, where the molecular weight of α-KG is 3 kDa (Shibuya et al., 2009). 3MST is found in cerebral Purkinje cells, mitral cells, hippocampal pyramidal neurons, and astrocytes (Shibuya et al., 2009). For H2S synthesis through the 3MST/CAT pathway, the mitochondrial cysteine concentration should be approximately 1 mM.

Under physiological conditions, CBS, CSE, and 3MST all play a vital role in H2S synthesis and facilitate the protective function of H2S in the CNS during aging and disease conditions.

Therapeutic Target and Cell Signaling of H2S

In several cell types, including human inducible pluripotent stem cell (hiPSC)-derived neurons, sulfide molecule inhibits mitochondrial complex IV and induces apoptosis (Jiang et al., 2016). At 3–30 fold higher concentrations, sulfide becomes toxic by binding to and inhibiting cytochrome C oxidase in complex IV of the electron transport chain (Jiang et al., 2016). On the other hand, sulfide at low concentrations (0.01 to 1 μM) donates electrons to complex II of the mitochondrial electron transport chain which stimulates ATP production (Kabil et al., 2014a). In addition to this, the electrophysiological characteristics of H9 embryonic stem cells (hESCs) are affected by H2S. At different concentrations, NaHS shows consistently altered hyper polarization (Wei et al., 2012). H2S might be a therapeutic target for neurodegenerative diseases in hiPSC-derived cortical neurons.

S-sulfhydration is a common process of cellular proteins initiated by H2S. With this process, H2S maintains the altered regulation of cellular proteins and enzymes (Gadalla and Snyder, 2010). During S-sulfhydration, the –SSH group is synthesized by the association of thiol groups, where –SSH shows enhanced chemical reactivity (Li et al., 2011). Most importantly, S-sulfhydration of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) can determine cytokine-induced memory impairment in the brain under physiological conditions (Mir et al., 2014). A cysteine must be oxidized prior to modification with H2S, as H2S cannot directly react with reduced thiols (Paul and Snyder, 2015). Although the cytosol is a predominantly reducing environment, S-sulfhydration can occur under certain conditions when the generation of ROS occurs in response to physiological stimuli (Paul and Snyder, 2015). Du et al. (2014) observed that macrophage inflammation by oxidized lipoproteins via the sulfhydration of NF-κB p65 at cys38 controlled the phosphorylation of NF-κB p65 (Gade et al., 2013). Exogenous H2S in microglial cells helps to increase Ca2+ influx through the plasma membrane (Abdulle et al., 2018). Elevated levels of Ca2+ are also necessary to activate microglial cells following lipopolysaccharide (LPS) challenge (Hoffmann et al., 2003), in which H2S plays an active role. To increase GSH synthesis, H2S also activates Cl- channels through K-ATP channels (Kabil et al., 2014a).

Antoxidative Regulatory Role of H2S

H2S exerts its antioxidant activity through the metabolism of GSH. Hamar et al. (2012) demonstrated that H2S is a poor antioxidant compared with other antioxidative agents (Jain et al., 2014). H2S increases the activity of cysteine and cysteine transporters to enhance the production of GSH. Additionally, oxidative stress is suppressed by H2S when 3MST is combined with CAT (Kolluru et al., 2013). Cellular damage occurs in newborn rats as a result of GSH deficiency. In the absence of mitochondrial CAT, mitochondria depend on GSH for the removal of H2O2 (Figure 2; Meister, 1992). Moreover, in astrocytes, H2S exerts its antioxidative effects against H2O2 by altering glutamate uptake. Several lines of evidence have shown that H2S enhances the GSH biosynthetic enzyme, γ-glutamyl cysteine sulfurtransferase (Searcy et al., 1995). H2S increases intracellular reduced glutathione (GSSH), where GSH is an important antioxidant and consists of glutamate, glycine, and cysteine. Among oxidized and reduced forms of cysteine, the reduced state is most prominent for GSH generation (Majid et al., 2013). When the ratio of GSH/GSSG decreases (Figure 2), oxidative stress increases and extracellular cysteine is reduced to produce GSH through the cysteine/glutamate antiport system (Kimura et al., 2010).

Figure 2.

Figure 2

Schematic representation of antioxidant regulatory role of H2S.

Under oxidative stress, the source of ROS increases hydrogen peroxide (H2O2) and super oxide (O•2). RNS increases peroxynitrite (NOOO). Simultaneously, glutathione (GSH) creates a redox cycle using nicotinamide adenine dinucleotide phosphate (NADPH) reducing agent associated with the enzyme, glutathione reductase (GR). On the other hand, peroxiredoxin (Prx) is a thiol based antioxidant, reacts with H2O2 at a very high rate to neutralize ROS from cell. Prx1, Prx2, and Prx4 are mostly found in nuclei rather than in cytoplasm. Oxidized thioredoxin (Trx) can be reversibly reduced by thioredoxin reductase (TrxR) enzyme in an NADPH-dependent manner, where Trx1 and Trx2 are localized in mitochondria. The combined action of glutamate-cysteine ligase catalytic subunit (GCLC) and glutamate-cysteine ligase modifier subunit (GCLM) helps GSH in the disposal of H2O2 in mitochondria as well as GSH reduced to GSSH in the presence of glutaredoxin (Grx). However, during S-nitrosylation of H2S, cysteine protein structure is being changed and increases the glutamate uptake which mediates H2S-induced antioxidative function. Overall, GSH, Trx, Prx, and Grx appear to have a protective action against oxidative stress. 3MST: 3-Mercaptopyruvate sulfurtransferase; H2S: hydrogen sulfide.

ROS are responsible for alterations of cellular diversity. SOD maintains various aspects of normal physiology by reducing oxidative stress. The initial function of SOD is to reduce O2•–, although another oxidative agent, H2O2, is generated in the process. In particular, SOD does not interfere with the generation of H2O2; rather, it retards the adjustment of ROS. For instance, SOD connects with Rac1, which regulates an isoform of nitric oxide synthase (NOX) (Harraz et al., 2008). Following this, NOX produces O2•–, indicating the position of SOD1 (Figure 3) (Nunomura et al., 2006). By contrast, the antioxidant function of SOD2 facilitates the function of proteases and DNA repair enzymes (Nunomura et al., 2006).

Figure 3.

Figure 3

Enzymatic antioxidant function of H2S against oxidative stress.

This schematic diagram explains various enzymatic antioxidant functions of H2S against oxidative stress. Among the antioxidants, the enzymatic antioxidants mostly take part in retard oxidative stress. Super oxide dismutase (SOD) is one of them and both cytosolic, Cu/Zn, SOD (SOD1), and mitochondrial MnSOD (SOD2) inhibit superoxide (O2•–) to form peroxynitrite (NOOO). The presence of NOOO causes tyrosine nitration, whereas tyrosine is an oxidative marker of oxidative stress. Moreover, SOD interferes with H2O2 formation from O2•– which forms 8-hydrodeoxyguanosine (8-OHdG), an oxidative damage of DNA. Exposure to excessive H2O2, oxidative degradation of cysteine to pyruvate and sulfate are prohibited by SOD and catalase (CAT). At the same time, glutathione peroxidase (Gpx) exhibits antioxidant function examined knockout mice that show specifically 21.8% at the age of 7 weeks against 8-OHdG-induced degradation. GSH: glutathione; GSSH: oxidized glutathione; H2S: hydrogen sulfide; OGD: oxygen glucose deprivation.

Cellular components are damaged by oxidative enzymes ROS or RNS. When free radicals like H2O2, O2•– are produced by cellular metabolic activities and environmental factors, Gpx provides antioxidant function against oxidative stress. Gpx is an intracellular enzyme of mitochondria and cytosol. The reducing equivalents produced by GSH help Gpx reduce high levels of H2O2 (Figure 3). Moreover, the reducing capacity of Gpx is mediated by GR, which catalyzes the reaction to form GSSH. The production of H2O2 causes microglial GSSH to increase by 30% (Navarro-Yepes et al., 2014). Gpx also neutralizes lipid peroxides from lipid alcohol. GSSH can induce the formation of disulfide bonds during oxidative stress. During the catalytic reaction, GSH is recycled (Dringen et al., 2000). The level of GSH in neurons, which is measured using a cysteine precursor, is low compared with that in astroglial cells (Navarro-Yepes et al., 2014).

CAT is a tetrameric enzyme found in numerous tissues that converts H2O2 to water molecules. According to Michaelis-Menten steady-state kinetics, CAT has a rate of 50 U/mL, where 1 U oxidizes 1 μmol of H2O2 (Scaglione et al., 2016). Additionally, due to oxidative stress, reduced levels of Aβ have been shown in hAPP mice that overexpress mitochondrial CAT. Catalase decreases 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ROS aggregation (Perier et al., 2010). CAT activity has been shown to increase with age as CAT inhibits the aggregation of 8-OHdG during aging (Perier et al., 2010). It triggers activation of glutathione S-transferases, which detoxifies endogenous electrophiles by binding GSH sites. To increase the catalytic function of above antioxidants, it will be necessary to increase binding site affinity, which would include the use of thiol substrates.

Contribution of H2S in Neurodegenerative Diseases

As an endogenous gasotransmitter, H2S is thought to play an important role in the CNS. The interrelationships between the cellular antioxidant function of H2S and age-associated diseases are discussed below (Figure 4).

Figure 4.

Figure 4

The interrelationship between antioxidant effects of H2S and oxidative stress-induced factors in age-related neurodegeneration.

This figure explains the cellular response of H2S against Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and Down’s syndrome (DS). The increased and decreased levels of H2S in cells play different roles in each neurodegenerative disease. H2S retards oxidative derivatives malonaldehyde (MDA) and 4-hydroxy-2-nonenal (4-HNE) in AD. In PD, cellular growth is regulated through protein kinases C (PKC), c-Jun NH2-terminal enzyme (JNK), and p38 mitogen activated protein kinase (p38 MAPK). These protein kinases decrease oxidative stress and facilitate antiapoptotic function. H2S also inhibits MDA in HD cells and facilitates N-acetylcysteine (NAC) function with GSH. In the case of DS, GSH retards overexpression of SOD1 and increased level of GSH inhibits oxidative deterioration. H2S: Hydrogen sulfide; SOD1: Cu/ZnSOD.

H2S and AD

AD is an age-associated neurodegenerative disease characterized by senile plaques containing Aβ peptide. H2S provides protection against oxidative stress by enhancing cell growth and storing mitochondrial function in a p38 and c-jun-N-terminal (JNK)-MAPK-dependent manner (Butterfield and Sultana, 2007). H2S also provides antioxidant function by enhancing the activity of γ-glutamyl cysteine sulfur transferase and cysteine transport, altering the levels of GSH in glutamate-mediated oxidative stress (Kimura and Kimura, 2004). Moreover, H2S inhibits the formation of Hcy-induced oxidative stress because the auto-oxidation of Hcy leads to O2•– and H2O2 formation (Wei et al., 2014). Therefore, Hcy is regarded as a novel therapeutic target for AD where H2S releases sildenafil to prevent against Hcy-induced oxidative stress and neurotxicity (Wei et al., 2014). S-propargyl-cyysteine, an S-allyl cysteine, might inhibit Aβ25–35-induced cognitive dysfunction in rats (Tan et al., 2010). Both S-allyl cysteine and S-propargyl-cyysteine are H2S-modulating agents (Tan et al., 2010). Additionally, H2S ameliorates oxidative stress-induced compounds, lipid oxidative products, and 4-HNE, to exert its antioxidant function (Mitani et al., 2002). H2S donor, NaHS, provides neural protection and significantly increases SOD activity in brain tissue to exert its antioxidant function. NaHS significantly inhibits hypochlorous acid-induced cytotoxicity, intracellular ROS, protein oxidation, and lipid peroxidation (Praschberger et al., 2013). Hypochlorous acid is an oxidative stress factor that is found at an elevated level in temporal and frontal cortex of the AD brains (Wei et al., 2014).

Although the effects of H2S have been elucidated using drug treatment, H2S donors via ROS signaling, and the formation of different oxidative stress-induced molecules, it will also be important to determine the abnormal characteristics of CBS during H2S release in AD.

H2S and PD

The mitochondrial complex I inhibitor, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, has been observed as MPP+ in PD. Oxidative damage in PD has also been demonstrated by mutations in mtDNA. In the familial forms of PD, PINK1 and DJ-1, and their roles in reducing levels of oxidative ROS have been linked to the familial forms of PD. The DJ-1 protein was detected as an oxidatively-damaged molecule in the brains of PD (Lu et al., 2012), and diminished function of PINK1 has been shown to result in decreased mitochondrial complex 1, which results in increased SOD activity and damage to proteins, lipids, and DNA. On the other hand, antioxidant activity of GSH has been demonstrated in the SN of PD patients at a reduced level that is capable of reducing oxidative damage. GSH either inhibits monoamine oxidase to mediate neuroprotection or increases the function of the electron transport system. Coenzyme Q10, such as selenium, is one example of a compound that can slow the generation of free radicals. Following administration of L-3,4-dihydroxyphenylalanine (L-DOPA), glycine/cysteine molecules are reduced in the presence of oxidative stress with the deposition of GSH, where GSH is oxidized to form GSSH, as previously described by Muller and Muhlack (2007).

On the other hand, many studies have addressed that generating hiPSC-derived neurons from patients with defined genetic mutations associated with PD (Ohnuki et al., 2009; Li et al., 2018). α-Syn, encoded by the substantia compacta nigra, is a pathological hallmark of PD (LaMarca et al., 2018). Cortical neurons generated from hiPSC lines of patients with α-Syn mutations exhibited nitrosative and endoplasmic reticulum stress and accumulation, leading to increased expression of α-Syn (Dettmer et al., 2015). L-DOPA is also used to treat PD patients, although it cannot retard the progression of PD and dyskinesia is a common side effect (Zhang et al., 2017). Moreover, plasma levels of homocysteine in cells become elevated in PD when L-DOPA is administered (Zhang et al., 2017). H2S release of the L-DOPA derivative ACS84 in a 6-OHDA-induced PD model demonstrated therapeutic action, particularly in SH-SY5Y neuroblastoma cells against 6-OHDA-induced oxidative stress, identifying MDA and decreased levels of GSH (Predmore et al., 2012). In addition, H2S induces nucleus translocation of Nrf2 by s-sulfhydrating cysteine-151 of keap1 and thereby enhances the anti-oxidative capacity of mammalian cells (Hu et al., 2010). H2S also inhibits the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase possibly through its suppressive effect on ERK phosphorylation (Cao et al., 2018).

Thus, the H2S-releasing L-DOPA derivative ACS84 reduces cellular damage by reducing oxidative stress in PD. H2S-mediated sulfhydration is an important mechanism for the attenuation of ROS generation, especially with respect to ACS84, and thus ACS84 may be useful in the treatment of PD.

H2S and HD

HD is a prototypical age-associated disease caused by CAG trinucleotide repeats in the HTT protein, for which neural dysfunction and death occur due to excitotoxicity, oxidative damage, and apoptosis. Ca2+ signaling in the mitochondria implies mitochondrial dysfunction. H2S exerts antioxidant function in HD patients through enzymatic antioxidants, including SOD, CAT, and Gpx. The GSH precursor N-acetyl transferase (NAC) provides protection against oxidative damage in HD (Schumann and Subramani, 2008). Moreover, administration of 3-nitropropainic acid before application of NAC reduces lesions in HD (Kimura and Kimura, 2004).

The level of CSE in HTT repeating cells (111 repeats) has been shown to be reduced by more than 90%. Similarly, the Q175 and R6/2 mouse models also exhibit reduced levels of CSE (Ali et al., 2007). In HD patients, CSE provides cytoprotection, which originates from cysteine proteins, and CSE depletion suggests cysteine loss (Truong et al., 2006). On the other hand, cystamine, the decarboxylated form of cysteine, provides neuroprotection in HD (Zhai et al., 2005). In response to enzymatic dysfunction in HD, Gpx provides broad-spectrum antioxidant function (Fraunberger et al., 2016). In the clinical study of patients affected by HD, it has been observed that cysteamine treated HD patients showed intolerance and cysteamine treatment showed adverse effects such as nausea and weight loss (Dubinsky and Gray, 2006). Moreover, motor subscales of the unified HD rating scale showed motoric impairment after 2 weeks (Dubinsky and Gray, 2006).

In summary, the combined action of GSH and NAC suggest new therapeutic possibilities for HD patients, although further studies will be necessary to understand the antioxidant mechanism induced by GSH and NAC in HD.

H2S and DS

The neuropathology of DS associated with dementia is related to age. The free radical metabolism of DS, which contributes to neuronal degradation, is also related to age. The mental retardation of DS occurs as a result of trisomy 21 (Das and Reeves, 2011). The overexpression of SOD1 gene as a response to the oxidative stress is observed in DS patients by the trisomic state, where SOD1 gene is located in chromosome 21. Apart from this, the main cause of DS is the elevated level of CBS enzyme. According to the study of Pogribna et al. (2001), DS patients with an increased level of CBS show decreased plasma levels of cystathionine, homocysteine, and SAM. Decreased homocysteine might play a role in the cognitive disability of DS. To maintain homocysteine levels, CBS catalyzes the folate and methionine cycle. CBS protein levels and enzymatic activity are increased in DS, and in particular, elevated CBS activity can lower the level of homocysteine (Hensley et al., 2010). As a consequence, carboxy transulfuration (1C-Ts) metabolism becomes imbalanced and H2S reaches toxic levels. Metabolism of the 1C-Ts complex, which includes the enzyme CBS (Hensley et al., 2010), has been linked with DS (Hensley et al., 2010). This metabolic alteration associated with CBS causes cognitive disability in DS (Kamoun, 2001). Accumulation of 8-OHdG is an oxidative hallmark found in the cytoplasm of cells in DS patients (Nunomura et al., 2000). SOD1 mediates antioxidant defense by catalyzing the dismutation of O2•– to molecular O2 and H2O2, which can be converted to water by CAT and Gpx (Perluigi and Butterfield, 2012).

In summary, DS is a result of the accumulation of H2S in the brain, particularly the increase in CBS. In general, Gpx activity in DS is not broad. For a better understanding of the antioxidant function of H2S as a gasotransmitter, clinical investigation will be necessary.

Interrelationship between H2S and Other Gasotransmitters

In spite of the several biological functions of H2S as a gasotransmitter, a recent study demonstrated an interaction between H2S and NO, which exhibited combined kinetics (Wu et al., 2018). According to reaction basis analysis, the reaction of H2S or –SH with disulfide represents a pathway of potential importance in the detection of H2S. To form S-nitrosothiols, nitroxyl, and nucleophiles, as well as reducing agents, H2S provides complementary action (Bruce King, 2013). The combined action of H2S and NO exhibits positive inotropic effects during inflammation (Kolluru et al., 2013). NOOO rapidly interacts with H2S, which produces sulfinyl nitrite and reduces oxidative molecules (Kolluru et al., 2013). Additionally, to observe H2S bioavailability in cells, endothelial cells treated with NO donors exhibited increased cysteine uptake in a dose-dependent manner (Kolluru et al., 2013).

Complementary action of CO and H2S has also been observed. To exert a physiological effect, CO and H2S act as a signaling molecule, depending on the cellular state. Generally, while hypoxia inhibits HO-1, more H2S is produced in the brain and CBS is considered a sensor for CO (Farrugia and Szurszewski, 2014). In the presence of HO-2 in neurons, CO inhibits the potential activity of CBS of astrocytes. In astrocytes, as well as other cell types, CO-mediated inhibition of CBS inhibits H2S release during vasodilation. In the presence of hypoxia, CO also inhibits CSE and, as a consequence, Ca2+-dependent K+ channels are closed in neurons (Olson, 2013). The enzymatic activity of CBS is changed when CO binds to the heme moiety of CBS.

In summary, the interactions between H2S, NO, and CO induce potential reactions capable of generating other biologically active species. Thus, further studies will be necessary to determine the complementary action of H2S, NO, and CO.

Future Perspectives and Concluding Remarks

Based on previous investigations, lower levels of H2S in the body are the root cause of age-associated diseases that hamper antioxidant function through cell signaling pathways in AD, PD, HD, and DS. Proper levels of H2S in the body have been shown to be necessary for GSH generation as well as to provide protection against oxidative damage.

As the antioxidant function of H2S involves GSH, the mechanisms underlying transsulfuration signaling and sulfur-containing molecules that include cysteine molecules may be helpful to clarify the antioxidant function. To address and understand further the biological as well as the clinical potential of H2S, suitable selection of H2S donors will also be crucial for the proper release of H2S in vitro and in vivo. Properly maintained enzymatic pathways are important for H2S release as well as its ability to induce the antioxidant functions of SOD, Gpx, and CAT. The role of H2S is likely to be cell-specific under different pathological conditions wherein H2S can provide proper neuromodulation against oxidative stress. Additional experimental and clinical studies will be necessary to understand further the pathophysiological pathways underlying aging to determine the possible therapeutic use of H2S-mediated antioxidant function.

Additional files:

Additional Table 1: Database search strategy.

Additional file: Open peer review reports 1 (104.8KB, pdf) and 2 (105.9KB, pdf) .

OPEN PEER REVIEW REPORT 1
NRR-15-653_Suppl1.pdf (104.8KB, pdf)
OPEN PEER REVIEW REPORT 2
NRR-15-653_Suppl2.pdf (105.9KB, pdf)

Footnotes

Conflicts of interest: The authors report no potential conflicts of interest.

Financial support: This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, No. 2018R1A2B6001123 (to NYJ), No. 2018R1D1A1B07040282 (to JJ).

Copyright license agreement: The Copyright License Agreement has been signed by all authors before publication.

Data sharing statement: Datasets analyzed during the current study are available from the corresponding author on reasonable request.

Plagiarism check: Checked twice by iThenticate.

Peer review: Externally peer reviewed.

Open peer reviewers: Agustin Cota-Coronado, CIATEJ AC, Mexico; Ubaldo Armato, University of Verona Medical School, Italy.

Funding: This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, No. 2018R1A2B6001123 (to NYJ), No. 2018R1D1A1B07040282 (to JJ).

C-Editor: Zhao M; S-Editor: Li CH; L-Editor: Song LP; T-Editor: Jia Y

References

  • 1.Abdulle A, van Goor H, Mulder D. Hydrogen sulfide: a therapeutic option in systemic sclerosis. Int J Mol Sci. 2018;19:4121. doi: 10.3390/ijms19124121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ali MY, Whiteman M, Low CM, Moore PK. Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway. J Endocrinol. 2007;195:105–112. doi: 10.1677/JOE-07-0184. [DOI] [PubMed] [Google Scholar]
  • 3.An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM. Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell. 2012;11:253–263. doi: 10.1016/j.stem.2012.04.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Attene-Ramos MS, Wagner ED, Plewa MJ, Gaskins HR. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res. 2006;4:9–14. doi: 10.1158/1541-7786.MCR-05-0126. [DOI] [PubMed] [Google Scholar]
  • 5.Bambrick LL, Fiskum G. Mitochondrial dysfunction in mouse trisomy 16 brain. Brain Res. 2008;1188:9–16. doi: 10.1016/j.brainres.2007.10.045. [DOI] [PubMed] [Google Scholar]
  • 6.Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. 2005;37:961–976. doi: 10.1016/j.biocel.2004.10.013. [DOI] [PubMed] [Google Scholar]
  • 7.Bose A, Beal MF. Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson’s disease. Eur J Neurosci. 2019;49:525–532. doi: 10.1111/ejn.14264. [DOI] [PubMed] [Google Scholar]
  • 8.Bruce King S. Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides. Free Radic Biol Med. 2013;55:1–7. doi: 10.1016/j.freeradbiomed.2012.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Butterfield DA, Sultana R. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis. 2007;12:61–72. doi: 10.3233/jad-2007-12107. [DOI] [PubMed] [Google Scholar]
  • 10.Butterfield DA, Swomley AM, Sultana R. Amyloid β-peptide (1–42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal. 2013;19:823–835. doi: 10.1089/ars.2012.5027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cai J, Shi X, Wang H, Fan J, Feng Y, Lin X, Yang J, Cui Q, Tang C, Xu G, Geng B. Cystathionine γ lyase–hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. Biochim Biophys Acta. 2016;1861:419–429. doi: 10.1016/j.bbalip.2016.03.001. [DOI] [PubMed] [Google Scholar]
  • 12.Cao L, Tan L, Jiang T, Zhu XC, Yu JT. Induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases. Mol Neurobiol. 2015;52:244–255. doi: 10.1007/s12035-014-8867-6. [DOI] [PubMed] [Google Scholar]
  • 13.Cao X, Cao L, Ding L, Bian JS. A new hope for a devastating disease: hydrogen sulfide in Parkinson’s disease. Mol Neurobiol. 2018;55:3789–3799. doi: 10.1007/s12035-017-0617-0. [DOI] [PubMed] [Google Scholar]
  • 14.Cartelli D, Amadeo A, Calogero AM, Casagrande FVM, De Gregorio C, Gioria M, Kuzumaki N, Costa I, Sassone J, Ciammola A. Parkin absence accelerates microtubule aging in dopaminergic neurons. Neurobiol Aging. 2018;61:66–74. doi: 10.1016/j.neurobiolaging.2017.09.010. [DOI] [PubMed] [Google Scholar]
  • 15.Chin LS, Olzmann JA, Li L. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem. 2008;15:47–60. doi: 10.2174/092986708783330692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 2015;47:e147. doi: 10.1038/emm.2014.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Das I, Reeves RH. The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech. 2011;4:596–606. doi: 10.1242/dmm.007716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Dettmer U, Newman AJ, Soldner F, Luth ES, Kim NC, Von Saucken VE, Sanderson JB, Jaenisch R, Bartels T, Selkoe D. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314. doi: 10.1038/ncomms8314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dinda B, Dinda M, Kulsi G, Chakraborty A, Dinda S. Therapeutic potentials of plant iridoids in Alzheimer’s and Parkinson’s diseases: A review. Eur J Med Chem. 2019;169:185–199. doi: 10.1016/j.ejmech.2019.03.009. [DOI] [PubMed] [Google Scholar]
  • 20.Dorrell MI, Aguilar E, Jacobson R, Yanes O, Gariano R, Heckenlively J, Banin E, Ramirez GA, Gasmi M, Bird A, Siuzdak G, Friedlander M. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J Clin Invest. 2009;119:611–623. doi: 10.1172/JCI35977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain: Metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem. 2000;267:4912–4916. doi: 10.1046/j.1432-1327.2000.01597.x. [DOI] [PubMed] [Google Scholar]
  • 22.Du J, Huang Y, Yan H, Zhang Q, Zhao M, Zhu M, Liu J, Chen SX, Bu D, Tang C. Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway. J Biol Chem. 2014;289:9741–9753. doi: 10.1074/jbc.M113.517995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dubinsky R, Gray C. CYTE‐I‐HD: Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington’s disease. Mov Disord Off J Mov Disord Soc. 2006;21:530–533. doi: 10.1002/mds.20756. [DOI] [PubMed] [Google Scholar]
  • 24.Farrugia G, Szurszewski JH. Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroenterology. 2014;147:303–313. doi: 10.1053/j.gastro.2014.04.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fraunberger EA, Scola G, Laliberté VLM, Duong A, Andreazza AC. Redox modulations, antioxidants, and neuropsychiatric disorders. Oxid Med Cell Longev. 2016;2016:4729192. doi: 10.1155/2016/4729192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem. 2010;113:14–26. doi: 10.1111/j.1471-4159.2010.06580.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gade AR, Kang M, Akbarali HI. Hydrogen sulfide as an allosteric modulator of ATP-sensitive potassium channels in colonic inflammation. Mol Pharmacol. 2013;83:294–306. doi: 10.1124/mol.112.081596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ganguly G, Chakrabarti S, Chatterjee U, Saso L. Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in alzheimer’s disease and parkinson’s disease. Drug Des Devel Ther. 2017;11:797–810. doi: 10.2147/DDDT.S130514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gemici B, Elsheikh W, Feitosa KB, Costa SKP, Muscara MN, Wallace JL. H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide. 2015;46:25–31. doi: 10.1016/j.niox.2014.11.010. [DOI] [PubMed] [Google Scholar]
  • 30.Hamar J, Solymar M, Tanai E, Cseplo P, Springo Z, Berta G, Debreceni B, Koller A. Bioassay-comparison of the antioxidant efficacy of hydrogen sulfide and superoxide dismutase in isolated arteries and veins. Acta Physiol Hung. 2012;99:411–419. doi: 10.1556/APhysiol.99.2012.4.5. [DOI] [PubMed] [Google Scholar]
  • 31.Hancock JT, Whiteman M. Hydrogen sulfide and cell signaling: team player or referee. Plant Physiol Biochem. 2014;78:37–42. doi: 10.1016/j.plaphy.2014.02.012. [DOI] [PubMed] [Google Scholar]
  • 32.Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schöneich C. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest. 2008;118:659. doi: 10.1172/JCI34060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hensley K, Venkova K, Christov A. Emerging biological importance of central nervous system lanthionines. Molecules. 2010;15:5581–5594. doi: 10.3390/molecules15085581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hewitt G, Jurk D, Marques FDM, Correia-Melo C, Hardy T, Gackowska A, Anderson R, Taschuk M, Mann J, Passos JF. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun. 2012;3:708. doi: 10.1038/ncomms1708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hipkiss AR. Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol. 2006;41:464–473. doi: 10.1016/j.exger.2006.03.004. [DOI] [PubMed] [Google Scholar]
  • 36.Hoffmann A, Kann O, Ohlemeyer C, Hanisch UK, Kettenmann H. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J Neurosci. 2003;23:4410–4419. doi: 10.1523/JNEUROSCI.23-11-04410.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hu L, Lu M, Tiong CX, Dawe GS, Hu G, Bian J. Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models. Aging Cell. 2010;9:135–146. doi: 10.1111/j.1474-9726.2009.00543.x. [DOI] [PubMed] [Google Scholar]
  • 38.Jain SK, Huning L, Micinski D. Hydrogen sulfide upregulates glutamate–cysteine ligase catalytic subunit, glutamate–cysteine ligase modifier subunit, and glutathione and inhibits interleukin-1β secretion in monocytes exposed to high glucose levels. Metab Syndr Relat Disord. 2014;12:299–302. doi: 10.1089/met.2014.0022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jiang J, Chan A, Ali S, Saha A, Haushalter KJ, Lam WL, Glasheen M, Parker J, Brenner M, Mahon SB, Patel HH, Ambasudhan R, Lipton SA, Pilz RB, Boss GR. Hydrogen sulfide--mechanisms of toxicity and development of an antidote. Sci Rep. 2016;6:20831. doi: 10.1038/srep20831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kabil O, Banerjee R. Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal. 2014;20:770–782. doi: 10.1089/ars.2013.5339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kabil O, Motl N, Banerjee R. H2S and its role in redox signaling. Biochim Biophys Acta. 2014a;1844:1355–1366. doi: 10.1016/j.bbapap.2014.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kabil O, Vitvitsky V, Banerjee R. Sulfur as a signaling nutrient through hydrogen sulfide. Annu Rev Nutr. 2014b;34:171–205. doi: 10.1146/annurev-nutr-071813-105654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kamoun P. Mental retardation in Down syndrome: a hydrogen sulfide hpothesis. Med Hypotheses. 2001;57:389–392. doi: 10.1054/mehy.2001.1377. [DOI] [PubMed] [Google Scholar]
  • 44.Kimura H. Hydrogen sulfide and polysulfides as biological mediators. Molecules. 2014;19:16146–16157. doi: 10.3390/molecules191016146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kimura H. Hydrogen sulfide and polysulfides as signaling molecules. Proc Japan Acad Ser B. 2015;91:131–159. doi: 10.2183/pjab.91.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kimura Y, Goto YI, Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal. 2010;12:1–13. doi: 10.1089/ars.2008.2282. [DOI] [PubMed] [Google Scholar]
  • 47.Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004;18:1165–1167. doi: 10.1096/fj.04-1815fje. [DOI] [PubMed] [Google Scholar]
  • 48.Kolluru GK, Shen X, Bir SC, Kevil CG. Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric oxide. 2013;35:5–20. doi: 10.1016/j.niox.2013.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.LaMarca EA, Powell SK, Akbarian S, Brennand KJ. Modeling neuropsychiatric and neurodegenerative diseases with induced pluripotent stem cells. Front Pediatr. 2018;6:82. doi: 10.3389/fped.2018.00082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Li H, Jiang H, Zhang B, Feng J. Modeling Parkinson’s disease using patient-specific induced pluripotent stem cells. J Parkinsons Dis. 2018;8:479–493. doi: 10.3233/JPD-181353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol. 2011;51:169–187. doi: 10.1146/annurev-pharmtox-010510-100505. [DOI] [PubMed] [Google Scholar]
  • 52.Li XN, Chen L, Luo B, Li X, Wang CY, Zou W, Zhang P, You Y, Tang XQ. Hydrogen sulfide attenuates chronic restrain stress-induced cognitive impairment by upreglulation of Sirt1 in hippocampus. Oncotarget. 2017;8:100396. doi: 10.18632/oncotarget.22237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–1217. doi: 10.1016/j.cell.2013.05.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lu M, Zhao FF, Tang JJ, Su CJ, Fan Y, Ding JH, Bian JS, Hu G. The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels. Antioxid Redox Signal. 2012;17:849–859. doi: 10.1089/ars.2011.4507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Majid AS, Majid AM, Yin ZQ, Ji D. Slow regulated release of H2S inhibits oxidative stress induced cell death by influencing certain key signaling molecules. Neurochem Res. 2013;38:1375–1393. doi: 10.1007/s11064-013-1034-z. [DOI] [PubMed] [Google Scholar]
  • 56.Meister A. Biosynthesis and functions of glutathione, an essential biofactor. J Nutr Sci Vitaminol (Tokyo) Spec No:1-6. 1992 doi: 10.3177/jnsv.38.special_1. [DOI] [PubMed] [Google Scholar]
  • 57.Mikami Y, Shibuya N, Ogasawara Y, Kimura H. Hydrogen sulfide is produced by cystathionine γ-lyase at the steady-state low intracellular Ca2+ concentrations. Biochem Biophys Res Commun. 2013;431:131–135. doi: 10.1016/j.bbrc.2013.01.010. [DOI] [PubMed] [Google Scholar]
  • 58.Miquel J, Economos AC, Fleming J, Johnson JE., Jr Mitochondrial role in cell aging. Exp Gerontol. 1980;15:575–591. doi: 10.1016/0531-5565(80)90010-8. [DOI] [PubMed] [Google Scholar]
  • 59.Mir S, Sen T, Sen N. Cytokine-induced GAPDH sulfhydration affects PSD95 degradation and memory. Mol Cell. 2014;56:786–795. doi: 10.1016/j.molcel.2014.10.019. [DOI] [PubMed] [Google Scholar]
  • 60.Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002;39:838–843. doi: 10.1161/01.hyp.0000013734.33441.ea. [DOI] [PubMed] [Google Scholar]
  • 61.Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer’s disease. Oxid Med Cell Longev. 2013;2013:940603. doi: 10.1155/2013/940603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Muhlack S, Welnic J, Woitalla D, Müller T. Exercise improves efficacy of levodopa in patients with Parkinson’s disease. Mov Disord. 2007;22:427–430. doi: 10.1002/mds.21346. [DOI] [PubMed] [Google Scholar]
  • 63.Muñoz-Espín D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol cell Biol. 2014;15:482. doi: 10.1038/nrm3823. [DOI] [PubMed] [Google Scholar]
  • 64.Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N, Li M, Pappa A, Martinez-Fong D, Del Razo LM. Antioxidant gene therapy against neuronal cell death. Pharmacol Ther. 2014;142:206–230. doi: 10.1016/j.pharmthera.2013.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006;65:631–641. doi: 10.1097/01.jnen.0000228136.58062.bf. [DOI] [PubMed] [Google Scholar]
  • 66.Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome. J Neuropathol Exp Neurol. 2000;59:1011–1017. doi: 10.1093/jnen/59.11.1011. [DOI] [PubMed] [Google Scholar]
  • 67.Ohnuki M, Takahashi K, Yamanaka S. Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol Chapter 4:Unit 4A. 2009 doi: 10.1002/9780470151808.sc04a02s9. [DOI] [PubMed] [Google Scholar]
  • 68.Oliver DMA, Reddy PH. Small molecules as therapeutic drugs for Alzheimer’s disease. Mol Cell Neurosci. 2019;96:47–62. doi: 10.1016/j.mcn.2019.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Olson KR. Hydrogen sulfide as an oxygen sensor. Clin Chem Lab Med. 2013;51:623–632. doi: 10.1515/cclm-2012-0551. [DOI] [PubMed] [Google Scholar]
  • 70.Onyango IG, Dennis J, Khan SM. Mitochondrial dysfunction in Alzheimer’s disease and the rationale for bioenergetics based therapies. Aging Dis. 2016;7:201. doi: 10.14336/AD.2015.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Paul BD, Snyder SH. H2S: a novel gasotransmitter that signals by sulfhydration. Trends Biochem Sci. 2015;40:687–700. doi: 10.1016/j.tibs.2015.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Perier C, Bove J, Dehay B, Jackson‐Lewis V, Rabinovitch PS, Przedborski S, Vila M. Apoptosis‐inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins. Ann Neurol. 2010;68:184–192. doi: 10.1002/ana.22034. [DOI] [PubMed] [Google Scholar]
  • 73.Perluigi M, Butterfield DA. Oxidative stress and down syndrome: A route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res. 2012;2012:724904. doi: 10.1155/2012/724904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Perridon BW, Leuvenink HG, Hillebrands JL, van Goor H, Bos EM. The role of hydrogen sulfide in aging and age-related pathologies. Aging (Albany NY) 2016;8:2264–2289. doi: 10.18632/aging.101026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet. 2001;69:88–95. doi: 10.1086/321262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Praschberger M, Hermann M, Laggner C, Jirovetz L, Exner M, Kapiotis S, Gmeiner BMK, Laggner H. Carbamoylation abrogates the antioxidant potential of hydrogen sulfide. Biochimie. 2013;95:2069–2075. doi: 10.1016/j.biochi.2013.07.018. [DOI] [PubMed] [Google Scholar]
  • 77.Predmore BL, Lefer DJ, Gojon G. Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal. 2012;17:119–140. doi: 10.1089/ars.2012.4612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Régnier V, Billard JM, Gupta S, Potier B, Woerner S, Paly E, Ledru A, David S, Luilier S, Bizot JC. Brain phenotype of transgenic mice overexpressing cystathionine β-synthase. PLoS One. 2012;7:e29056. doi: 10.1371/journal.pone.0029056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Rocha EM, De Miranda B, Sanders LH. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Neurobiol Dis. 2018;109:249–257. doi: 10.1016/j.nbd.2017.04.004. [DOI] [PubMed] [Google Scholar]
  • 80.Rodríguez-Sureda V, Vilches Á, Sánchez O, Audí L, Domínguez C. Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid Med Cell Longev. 2015;2015:509241. doi: 10.1155/2015/509241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Rose P, Moore PK, Zhu YZ. H2S biosynthesis and catabolism: new insights from molecular studies. Cell Mol Life Sci. 2017;74:1391–1412. doi: 10.1007/s00018-016-2406-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Ross CA, Akimov SS. Human-induced pluripotent stem cells: potential for neurodegenerative diseases. Hum Mol Genet. 2014;23:R17–26. doi: 10.1093/hmg/ddu204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Scaglione CN, Xu Q, Ramanujan VK. Direct measurement of catalase activity in living cells and tissue biopsies. Biochem Biophys Res Commun. 2016;470:192–196. doi: 10.1016/j.bbrc.2016.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Schuchmann S, Heinemann U. Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down’s syndrome. Free Radic Biol Med. 2000;28:235–250. doi: 10.1016/s0891-5849(99)00226-9. [DOI] [PubMed] [Google Scholar]
  • 85.Schumann U, Subramani S. Special delivery from mitochondria to peroxisomes. Trends Cell Biol. 2008;18:253–256. doi: 10.1016/j.tcb.2008.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Searcy DG, Whitehead JP, Maroney MJ. Interaction of Cu, Zn superoxide dismutase with hydrogen sulfide. Arch Biochem Biophys. 1995;318:251–263. doi: 10.1006/abbi.1995.1228. [DOI] [PubMed] [Google Scholar]
  • 87.Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell. 2012;45:13–24. doi: 10.1016/j.molcel.2011.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’agostino RB, Wilson PWF, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–483. doi: 10.1056/NEJMoa011613. [DOI] [PubMed] [Google Scholar]
  • 89.Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal. 2009;11:703–714. doi: 10.1089/ars.2008.2253. [DOI] [PubMed] [Google Scholar]
  • 90.Singh S, Banerjee R. PLP-dependent H2S biogenesis. Biochim Biophys Acta (BBA)-Proteins Proteomics. 2011;1814:1518–1527. doi: 10.1016/j.bbapap.2011.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Tan BH, Wong PT-H, Bian J-S. Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem Int. 2010;56:3–10. doi: 10.1016/j.neuint.2009.08.008. [DOI] [PubMed] [Google Scholar]
  • 92.Teng H, Wu B, Zhao K, Yang G, Wu L, Wang R. Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease. Proc Natl Acad Sci U S A. 2013;110:12679–12684. doi: 10.1073/pnas.1308487110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Truong DH, Eghbal MA, Hindmarsh W, Roth SH, O’brien PJ. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab Rev. 2006;38:733–744. doi: 10.1080/03602530600959607. [DOI] [PubMed] [Google Scholar]
  • 94.Tyagi N, Moshal KS, Sen U, Vacek TP, Kumar M, Hughes WM, Jr, Kundu S, Tyagi SC. H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal. 2009;11:25–33. doi: 10.1089/ars.2008.2073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Viña J, Borras C, Abdelaziz KM, Garcia-Valles R, Gomez-Cabrera MC. The free radical theory of aging revisited: the cell signaling disruption theory of aging. Antioxid Redox Signal. 2013;19:779–787. doi: 10.1089/ars.2012.5111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Wei H, Zhang G, Qiu S, Lu J, Sheng J, Tan G, Wong P, Gan SU, Shim W. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes. PLoS One. 2012;7:e50641. doi: 10.1371/journal.pone.0050641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Wei HJ, Li X, Tang XQ. Therapeutic benefits of H2S in Alzheimer’s disease. J Clin Neurosci. 2014;21:1665–1669. doi: 10.1016/j.jocn.2014.01.006. [DOI] [PubMed] [Google Scholar]
  • 98.Wu D, Hu Q, Zhu D. An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system. Oxid Med Cell Longev. 2018;2018:4579140. doi: 10.1155/2018/4579140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Xie ZZ, Liu Y, Bian JS. Hydrogen sulfide and cellular redox homeostasis. Oxid Med Cell Longev. 2016;2016:1–12. doi: 10.1155/2016/6043038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Yamanishi M, Kabil O, Sen S, Banerjee R. Structural insights into pathogenic mutations in heme-dependent cystathionine-β-synthase. J Inorg Biochem. 2006;100:1988–1995. doi: 10.1016/j.jinorgbio.2006.08.020. [DOI] [PubMed] [Google Scholar]
  • 101.Zhai W, Jeong H, Cui L, Krainc D, Tjian R. In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell. 2005;123:1241–1253. doi: 10.1016/j.cell.2005.10.030. [DOI] [PubMed] [Google Scholar]
  • 102.Zhang J, Ding Y, Wang Z, Kong Y, Gao R, Chen G. Hydrogen sulfide therapy in brain diseases: from bench to bedside. Med Gas Res. 2017;7:113. doi: 10.4103/2045-9912.208517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Zhao K, Ju Y, Li S, Altaany Z, Wang R, Yang G. S‐sulfhydration of MEK1 leads to PARP‐1 activation and DNA damage repair. EMBO Rep. 2014;15:792–800. doi: 10.1002/embr.201338213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang SH, Tan CS, Whiteman M, Lu J, Moore PK. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol. 2007;102:261–268. doi: 10.1152/japplphysiol.00096.2006. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

OPEN PEER REVIEW REPORT 1
NRR-15-653_Suppl1.pdf (104.8KB, pdf)
OPEN PEER REVIEW REPORT 2
NRR-15-653_Suppl2.pdf (105.9KB, pdf)

Articles from Neural Regeneration Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES